We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
We will guide you from your first visit to the centre, allowing you to find all the departments and make the most of our facilities. Whatever the reason for your visit, we will explain how to get about the hospital.
Rare diseases are those that affect between 6% and 8% of the population. It is estimated that there are more than 7,000 in the world. Most rare diseases have a genetic origin, affect various organs and systems of our body, and cause intellectual or physical disabilities.
The complexity of most rare diseases requires multidisciplinary care with professionals from different medical specialities, case management for nursing, psychological support and also social work.
The Vall d'Hebron Barcelona Hospital Campus is home to more than 100 specialist professionals dedicated to the care of more than 2,000 rare diseases. Apart from treating the most rare diseases of any centre in Spain, it is one of the leading hospitals in Europe in this field. In fact, Vall d'Hebron is part of 20 European reference networks, known as ERN. This makes this hospital a highly specialised centre for rare diseases, from birth to adulthood, through a networked system that allows sharing of resources and knowledge with other world-class hospitals.
Adult and child
This concentration of patients with rare diseases at Vall d'Hebron improves knowledge and promotes research. Research in this field focuses above all on improving diagnostic capacity for diseases that are often difficult to diagnose and on developing new treatments for those diseases. In the case of diseases with few patients, publicly funded research is often the main avenue for the discovery of new drugs, and public health is the framework that provides the public with access to high medication complexity.
For more information, contact the Rare Disease Team at the following email address: minoritaries-VH@vhebron.net
Endocrinology and Nutrition
Echocardiogram and cardiac imaging unit
Paediatric Oncological Surgery Unit
Paediatric Hospitalisation and Hospital Paediatrics Unit
Hereditary Angioedema Unit
Diagnostic and Interventional Haemodynamics
Congenital Heart Disease in Adolescents and Adults
Paediatric emergency care
Prematurity Prevention Unit
Paediatric Maxillofacial Surgery
Urology and Paediatric Kidney Transplant
Aortic pathology and Marfan syndrome
Cardiovascular Critical Care Unit
Neonatal and Foetal Surgery
Corneal and Ocular Surface Section
Inherited Heart Disease
Paediatric Oncology and Haematology
Haematology and Haemotherapy
Uveitis and Eye Inflammation
Oral and Maxillofacial Surgery
Otolaryngology (Ear, Nose and Throat)
Clinical and molecular genetics
Oculoplastic and Orbital Surgery
Children's Hospital and Woman's Hospital
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to email@example.com, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.